Alfred E. Mann has been a significant figure in the biotechnology and medical device industries for decades. He founded MannKind Corporation, which specializes in diabetes treatment, and has also been involved in several other ventures like MiniMed, Advanced Bionics, and...

Alfred E. Mann has been a significant figure in the biotechnology and medical device industries for decades. He founded MannKind Corporation, which specializes in diabetes treatment, and has also been involved in several other ventures like MiniMed, Advanced Bionics, and Pacesetter Systems. With a strong background in physics from UCLA, he has leveraged his knowledge to create innovative medical solutions. Notably, Alfred was the largest shareholder of MannKind, holding approximately 154 million shares at one point, demonstrating significant personal investment in the company’s success. He even made headlines with his insider trading, engaging in substantial stock sales valued at over a million dollars during peak periods. With a no-nonsense compensation approach, Mann reported a salary from the company while emphasizing a philosophy focused on aligning executive interests with those of shareholders. Throughout his career, he has created and led companies that have addressed critical medical needs, showcasing a unique blend of engineering expertise and entrepreneurial spirit.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Mannkind CEOs

M

Alfred E. Mann

Founder and Ex-CEO of Mannkind

Education

Bachelor's and Master's degrees in Physics from UCLA

Field of Expertise

Technology & Engineering - Engineering

Sector of Economy

Healthcare

Born

December 1, 1925 - 99 years ago

CEO of Mannkind for

11 years 3 months (Oct 2003 - Jan 2015)

Previous Experience

Founder and CEO of MiniMed, Inc.

Rivals

Competitors/colleagues of Alfred E. Mann

Holdings

See how much did Alfred E. Mann make over time.

Alfred E. Mann's stock holdings in MannKind Corporation peaked at around 154 million shares, making him the largest shareholder. His investments fluctuated over the years; at times, he conducted insider trades worth over a million dollars each month, demonstrating a...

Alfred E. Mann's stock holdings in MannKind Corporation peaked at around 154 million shares, making him the largest shareholder. His investments fluctuated over the years; at times, he conducted insider trades worth over a million dollars each month, demonstrating a strong belief in his company's potential. While he saw some declines in stock value, he consistently maintained a substantial stake in MannKind. As of early 2024, despite the ups and downs of the stock market, Mann continues to hold significant influence through his equity in the company, reflecting his unwavering commitment to its vision.

Mar 17, 2025

M

shares

MNKD @ $5.24

Charitable Transactions

MNKD

3,260,982 shares

MNKD

Recent Charitable Transactions

MNKD

16,304,910 shares

MNKD

Dec 31, 2012

Charity

Insider Trading

See recent insider trades of Alfred E. Mann.

MNKD

51,600 shares

MNKD

Aug 11, 2014

Received

MNKD

44,000 shares

MNKD

Aug 22, 2013

Received

MNKD

15,799,910 shares

MNKD

Dec 31, 2012

Charity

MNKD

16,304,910 shares

MNKD

Dec 31, 2012

Charity

MNKD

$103.60M

MNKD at $2.59/share

Dec 21, 2012

Purchase

MNKD

90,000 shares

MNKD

Aug 16, 2012

Received

MNKD

$77.19M

MNKD at $2.47/share

Jun 27, 2012

Purchase

MNKD

85,000 shares

MNKD

Aug 18, 2011

Received

MNKD

54,100 shares

MNKD

Mar 3, 2011

Received

MNKD

$5.01M

MNKD at $7.15/share

Jan 26, 2011

Purchase

Compensation History

See how much did Alfred E. Mann make over time.

In terms of compensation, Alfred E. Mann's financial rewards varied widely throughout his tenure. In 2016, his total compensation was reported at just $40,615, primarily reflecting his salary, as other compensation forms, like bonuses and stock awards, were absent. This lack of additional incentives was due to unmet performance targets. Looking back to 2013, he earned around $6 million, including bonuses and vested stock, indicating a more favorable year. While his approach to compensation focuses on aligning interests with shareholders, the stark difference in figures over the years highlights the challenges faced by the company and his strategic decisions about when to reward himself.

Year

2016

Total Compensation

$40.62K

Salary

$40.62K

Board Justification

The compensation philosophy is designed to attract and retain high-caliber executives while aligning their interests with those of the stockholders.

Bonus

$0.00

Board Justification

No bonuses were paid in 2016 as the target bonuses were not achieved.

Other

$0.00

Board Justification

No other compensation was reported for Mr. Mann in 2016.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards were vested in 2016 as Mr. Mann ceased to be the CEO in January 2016.

Performance Metrics

The performance metrics for 2016 were not met, resulting in no bonuses being paid.

Other Mannkind CEOs

Here are other CEOs of Mannkind

Hakan S. Edstrom

Ex-CEO of Mannkind

January 2015 - November 2015